Balaxi Pharmaceuticals standalone net profit declines 12.07% in the December 2025 quarter
Sales rise 120.34% to Rs 24.59 crore
Net profit of Balaxi Pharmaceuticals declined 12.07% to Rs 1.53 crore in the quarter ended December 2025 as against Rs 1.74 crore during the previous quarter ended December 2024. Sales rose 120.34% to Rs 24.59 crore in the quarter ended December 2025 as against Rs 11.16 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales24.5911.16 120 OPM %5.610.81 -PBDT2.272.44 -7 PBT2.122.33 -9 NP1.531.74 -12Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 28 2026 | 4:51 PM IST